Huge congratulations to Abigail Coetzee - now DR Abigail Coetzee - who has been awarded her PhD.
A PCRF-funded project has identified a new way to kill pancreatic cancer cells by ‘pulling the plug’ on the energy generator that fuels calcium pumps on their cell surface.
A team of researchers from Queen Mary University of London and Zhengzhou University in China have taken the first steps towards the development of a vaccine for pancreatic cancer.
Some 150 people attended the 2019 PCRF Supporters Conference at the Cavendish Conference Centre in London on 29 November.
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients.
Treatment of pancreatic cancer might be enhanced by zapping tumours with electricity alongside drug treatments, according to a PCRF-funded project at University College Cork.
PCRF-funded scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.
The recent news that the drug olaparib delayed the progress of advanced pancreatic cancer in patients who have faults in the BRCA1 and 2 genes underlines the relevance and importance of a PCRF-funded research project being carried out by Dr Mairéad McNamara from the University of Manchester and The Christie NHS Foundation Trust.
A ‘precision drug’ designed to target specific genetic faults within cancer cells has caused cautious excitement, by delaying the progression of some advanced pancreatic cancers after chemotherapy treatment.
Seven innovative research projects tackling pancreatic cancer have been awarded grants by the national charity Pancreatic Cancer Research Fund (PCRF) totalling £1.2M.